Update endokrine Hypertonie
暂无分享,去创建一个
F. Beuschlein | M. Reincke | J. Sauerbeck | B. Lechner | A. Osswald-Kopp | G. Rubinstein | D. Heinrich | S. Nölting | D. Heinrich | F. Beuschlein | Benjamin Lechner | Daniel A. Heinrich
[1] P. Chanson,et al. Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN. , 2017, European journal of endocrinology.
[2] D. Loriaux. Diagnosis and Differential Diagnosis of Cushing's Syndrome. , 2017, The New England journal of medicine.
[3] W. Young,et al. Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement , 2017 .
[4] F. Veglio,et al. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe , 2016, Journal of hypertension.
[5] A. Tabarin,et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.
[6] A. Dominiczak,et al. 2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. , 2016, Journal of hypertension.
[7] W. Young,et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.
[8] W. Young,et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.
[9] V. Montori,et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.
[10] A. Pessina,et al. Clinical Use of Laboratory Tests for the Identification of Secondary Forms of Arterial Hypertension , 2007, Critical reviews in clinical laboratory sciences.
[11] G. Reimondo,et al. Subclinical Cushing's syndrome in adrenal incidentalomas. , 2005, Endocrinology and metabolism clinics of North America.
[12] K. Reynolds,et al. Global burden of hypertension: analysis of worldwide data , 2005, The Lancet.
[13] W. Young,et al. Role for adrenal venous sampling in primary aldosteronism. , 2004, Surgery.
[14] H. Hense,et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. , 2003, JAMA.
[15] PHÆOCHROMOCYTOMA , 1954, Journal of the Indian Medical Association.
[16] Fiorenzo Gaita,et al. Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis. , 2018, The lancet. Diabetes & endocrinology.
[17] Katsutoshi Takahashi,et al. Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan , 2018, Hypertension.
[18] G. Curhan,et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. , 2018, The lancet. Diabetes & endocrinology.